Xtant Medical Holdings, Inc.
XTNT
$0.3967
-$0.0075-1.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.02M | -3.86M | -4.40M | -4.30M | 9.23M |
| Total Depreciation and Amortization | 1.07M | 998.00K | 1.01M | 1.02M | 883.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.71M | 1.51M | 1.27M | 1.03M | -12.44M |
| Change in Net Operating Assets | 525.00K | -3.73M | -3.63M | 1.35M | -1.51M |
| Cash from Operations | -1.72M | -5.09M | -5.76M | -915.00K | -3.83M |
| Capital Expenditure | -2.10M | -564.00K | -773.00K | -363.00K | -223.00K |
| Sale of Property, Plant, and Equipment | 95.00K | 84.00K | 99.00K | 105.00K | 15.00K |
| Cash Acquisitions | -- | -- | -- | -2.06M | -4.45M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.01M | -480.00K | -674.00K | -2.31M | -4.66M |
| Total Debt Issued | 26.75M | 34.12M | 30.45M | 22.74M | 18.99M |
| Total Debt Repaid | -26.43M | -27.51M | -24.81M | -22.27M | -20.14M |
| Issuance of Common Stock | 4.47M | -- | -- | 0.00 | 14.01M |
| Repurchase of Common Stock | -93.00K | 0.00 | -17.00K | -142.00K | -119.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 615.00K | -179.00K | -436.00K | -- | 101.00K |
| Cash from Financing | 5.31M | 6.43M | 5.18M | 325.00K | 12.84M |
| Foreign Exchange rate Adjustments | 21.00K | -12.00K | -49.00K | 77.00K | -53.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.61M | 854.00K | -1.30M | -2.83M | 4.30M |
